Ferrer-Barceló et al., in a RCT that compared i.v. FCM vs. oral ferrous sulfate in patients with anemia after acute non-variceal GIB, demonstrated that FCM offers a faster and more efficient normalization of s-Hb levels and iron repletion stores compared to oral iron therapy (15). This evidence concerns the gene GSTM1 and anemia.